Annual Net Income
-$30.09 M
-$3.13 M-11.62%
31 December 2023
Summary:
Atossa Therapeutics annual net profit is currently -$30.09 million, with the most recent change of -$3.13 million (-11.62%) on 31 December 2023. During the last 3 years, it has fallen by -$9.49 million (-46.04%). ATOS annual net income is now -2668.79% below its all-time high of -$1.09 million, reached on 31 December 2010.ATOS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$7.23 M
-$1.18 M-19.52%
30 September 2024
Summary:
Atossa Therapeutics quarterly net profit is currently -$7.23 million, with the most recent change of -$1.18 million (-19.52%) on 30 September 2024. Over the past year, it has increased by +$524.00 thousand (+6.76%). ATOS quarterly net income is now -3632.00% below its all-time high of $204.70 thousand, reached on 30 September 2016.ATOS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$26.91 M
-$1.00 M-3.86%
30 September 2024
Summary:
Atossa Therapeutics TTM net profit is currently -$26.91 million, with the most recent change of -$1.00 million (-3.86%) on 30 September 2024. Over the past year, it has increased by +$3.18 million (+10.58%). ATOS TTM net income is now -28961.56% below its all-time high of -$92.60 thousand, reached on 30 September 2009.ATOS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATOS Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +6.8% | +10.6% |
| 3 y3 years | -46.0% | -49.6% | -30.6% |
| 5 y5 years | -74.6% | -176.2% | -56.1% |
ATOS Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -46.0% | at low | -51.1% | +26.4% | -30.6% | +14.9% |
| 5 y | 5 years | -74.6% | at low | -176.2% | +26.4% | -110.9% | +14.9% |
| alltime | all time | -2668.8% | at low | -3632.0% | +26.4% | <-9999.0% | +14.9% |
Atossa Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.23 M(+19.5%) | -$26.91 M(+3.9%) |
| June 2024 | - | -$6.05 M(+2.9%) | -$25.91 M(-12.7%) |
| Mar 2024 | - | -$5.88 M(-24.2%) | -$29.69 M(-1.3%) |
| Dec 2023 | -$30.09 M(+11.6%) | -$7.75 M(+24.5%) | -$30.09 M(+0.9%) |
| Sept 2023 | - | -$6.23 M(-36.6%) | -$29.83 M(-5.6%) |
| June 2023 | - | -$9.83 M(+56.5%) | -$31.61 M(+11.1%) |
| Mar 2023 | - | -$6.28 M(-16.2%) | -$28.45 M(+5.5%) |
| Dec 2022 | -$26.96 M(+30.8%) | -$7.49 M(-6.5%) | -$26.96 M(+10.9%) |
| Sept 2022 | - | -$8.01 M(+20.1%) | -$24.30 M(+13.1%) |
| June 2022 | - | -$6.67 M(+39.4%) | -$21.49 M(-1.7%) |
| Mar 2022 | - | -$4.79 M(-1.0%) | -$21.85 M(+6.1%) |
| Dec 2021 | -$20.61 M(+15.6%) | -$4.83 M(-7.0%) | -$20.61 M(-11.4%) |
| Sept 2021 | - | -$5.20 M(-26.2%) | -$23.26 M(+7.9%) |
| June 2021 | - | -$7.04 M(+99.0%) | -$21.55 M(+17.0%) |
| Mar 2021 | - | -$3.54 M(-52.7%) | -$18.42 M(+3.3%) |
| Dec 2020 | -$17.83 M(+3.4%) | -$7.48 M(+114.4%) | -$17.83 M(+37.5%) |
| Sept 2020 | - | -$3.49 M(-10.6%) | -$12.96 M(+1.6%) |
| June 2020 | - | -$3.91 M(+32.5%) | -$12.76 M(-20.8%) |
| Mar 2020 | - | -$2.95 M(+12.6%) | -$16.11 M(-6.5%) |
| Dec 2019 | -$17.24 M(+51.2%) | -$2.62 M(-20.3%) | -$17.24 M(+3.2%) |
| Sept 2019 | - | -$3.29 M(-54.8%) | -$16.70 M(-0.1%) |
| June 2019 | - | -$7.26 M(+78.3%) | -$16.72 M(+22.9%) |
| Mar 2019 | - | -$4.07 M(+96.0%) | -$13.60 M(+19.3%) |
| Dec 2018 | -$11.40 M(+40.4%) | -$2.08 M(-37.2%) | -$11.40 M(+0.8%) |
| Sept 2018 | - | -$3.31 M(-20.1%) | -$11.32 M(+11.0%) |
| June 2018 | - | -$4.14 M(+121.0%) | -$10.19 M(+22.9%) |
| Mar 2018 | - | -$1.87 M(-6.0%) | -$8.29 M(+2.1%) |
| Dec 2017 | -$8.12 M | -$1.99 M(-8.8%) | -$8.12 M(-6.1%) |
| Sept 2017 | - | -$2.18 M(-2.5%) | -$8.65 M(+38.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$2.24 M(+31.6%) | -$6.26 M(+9.0%) |
| Mar 2017 | - | -$1.70 M(-32.5%) | -$5.74 M(-9.8%) |
| Dec 2016 | -$6.37 M(-59.6%) | -$2.52 M(-1332.8%) | -$6.37 M(-27.7%) |
| Sept 2016 | - | $204.70 K(-111.9%) | -$8.81 M(-33.9%) |
| June 2016 | - | -$1.72 M(-26.0%) | -$13.33 M(-9.6%) |
| Mar 2016 | - | -$2.33 M(-53.1%) | -$14.75 M(-6.4%) |
| Dec 2015 | -$15.76 M(+7.5%) | -$4.96 M(+14.9%) | -$15.76 M(-5.1%) |
| Sept 2015 | - | -$4.32 M(+37.3%) | -$16.61 M(+6.9%) |
| June 2015 | - | -$3.15 M(-5.7%) | -$15.54 M(-0.3%) |
| Mar 2015 | - | -$3.34 M(-42.6%) | -$15.58 M(+6.3%) |
| Dec 2014 | -$14.66 M(+35.9%) | -$5.81 M(+79.1%) | -$14.66 M(+26.3%) |
| Sept 2014 | - | -$3.25 M(+1.8%) | -$11.60 M(-2.2%) |
| June 2014 | - | -$3.19 M(+32.2%) | -$11.86 M(+5.4%) |
| Mar 2014 | - | -$2.41 M(-12.6%) | -$11.25 M(+4.4%) |
| Dec 2013 | -$10.78 M(+112.3%) | -$2.76 M(-21.2%) | -$10.78 M(+10.8%) |
| Sept 2013 | - | -$3.50 M(+35.5%) | -$9.73 M(+32.0%) |
| June 2013 | - | -$2.58 M(+33.1%) | -$7.37 M(+23.8%) |
| Mar 2013 | - | -$1.94 M(+13.8%) | -$5.96 M(+17.3%) |
| Dec 2012 | -$5.08 M(+47.6%) | -$1.71 M(+49.2%) | -$5.08 M(+10.9%) |
| Sept 2012 | - | -$1.14 M(-2.1%) | -$4.58 M(-2.7%) |
| June 2012 | - | -$1.17 M(+9.9%) | -$4.71 M(+9.5%) |
| Mar 2012 | - | -$1.06 M(-11.8%) | -$4.30 M(+24.0%) |
| Dec 2011 | -$3.44 M(+216.7%) | -$1.21 M(-5.3%) | -$3.47 M(+33.1%) |
| Sept 2011 | - | -$1.27 M(+67.8%) | -$2.60 M(+43.6%) |
| June 2011 | - | -$758.40 K(+229.2%) | -$1.81 M(+44.8%) |
| Mar 2011 | - | -$230.40 K(-32.7%) | -$1.25 M(+22.5%) |
| Dec 2010 | -$1.09 M | -$342.60 K(-29.0%) | -$1.02 M(+50.4%) |
| Sept 2010 | - | -$482.40 K(+144.7%) | -$679.50 K(+134.6%) |
| June 2010 | - | -$197.10 K(+112.9%) | -$289.70 K(+212.9%) |
| Sept 2009 | - | -$92.60 K | -$92.60 K |
FAQ
- What is Atossa Therapeutics annual net profit?
- What is the all time high annual net income for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly net income year-on-year change?
- What is Atossa Therapeutics TTM net profit?
- What is the all time high TTM net income for Atossa Therapeutics?
- What is Atossa Therapeutics TTM net income year-on-year change?
What is Atossa Therapeutics annual net profit?
The current annual net income of ATOS is -$30.09 M
What is the all time high annual net income for Atossa Therapeutics?
Atossa Therapeutics all-time high annual net profit is -$1.09 M
What is Atossa Therapeutics quarterly net profit?
The current quarterly net income of ATOS is -$7.23 M
What is the all time high quarterly net income for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly net profit is $204.70 K
What is Atossa Therapeutics quarterly net income year-on-year change?
Over the past year, ATOS quarterly net profit has changed by +$524.00 K (+6.76%)
What is Atossa Therapeutics TTM net profit?
The current TTM net income of ATOS is -$26.91 M
What is the all time high TTM net income for Atossa Therapeutics?
Atossa Therapeutics all-time high TTM net profit is -$92.60 K
What is Atossa Therapeutics TTM net income year-on-year change?
Over the past year, ATOS TTM net profit has changed by +$3.18 M (+10.58%)